The Pennant Group (NASDAQ: PNTG) expects emerging rebounds in skilled nursing and assisting living — and its pipeline of forthcoming acquisitions — to offset the impact of continuing labor headwinds. The company reduced its guidance for calendar year 2022 in the wake of falling hospice lengths of stay, rising wages, the return of Medicare sequestration, […]
The Pennant Group (NASDAQ: PNTG) plans to ramp up acquisition activity in the second half of the year and into 2023, with a number of hospice and home health deals in its pipeline. The company has been aggressive on acquisitions for the past two years, but paused in early 2022 to integrate its most recently […]
Brent Guerisoli effective Aug. 1 will become CEO of The Pennant Group Inc. (NASDAQ: PNTG). Current CEO Daniel Walker will retire from the position but remain board chairman. Guerisoli joined Pennant in 2012 and, until August, served as the company’s president and COO. In that role, he has been involved heavily in leadership recruitment and […]
Recent acquisitions and joint ventures by The Pennant Group (NASDAQ: PNTG) are fueling bottom-line growth for the Idaho-based senior services provider. The financial boost from acquired home health and hospice agencies helped mitigate COVID-related struggles like rising costs and labor headwinds. Case in point, the 15 deals the company completed in 2020 collectively grew EBITDA […]
The Pennant Group’s (NASDAQ: PNTG) strategy for pursuing potential acquisitions is rooted in an operational model that emphasizes the role of local agency leaders. This approach will continue as transaction opportunities arise for Pennant, which CEO Danny Walker describes as a “growth company.” For prospective deals, Pennant scouts for agencies that show strong promise for […]
The Pennant Group intends to pick up the pace in acquisitions after a slowdown in the last quarter of 2021. After staying aggressive on acquisitions for the past two years, the company took a break to integrate and financially recharge recently purchased assets amid COVID headwinds. Pennant completed 11 acquisitions during 2021 in addition to […]
Although 2% sounds like a small number, it can mean financial life or death for some hospices, particularly small community-based providers. These organizations are once again waiting to see if the federal government will extend the current moratorium on Medicare sequestration, uncertain about their programs’ sustainability without such relief. Established in 2014 by the Budget […]
Despite prevailing COVID-19 headwinds, the hospice and home health mergers and acquisitions market shows no signs of slowing. Labor shortages plaguing the industry may be spurring additional activity as the dwindling workforce is limiting some providers’ ability to grow organically. A number of the larger strategic buyers — LHC Group (NASDAQ: LHCG), Amedisys (NASDAQ: AMED), […]
The Pennant Group (NASDAQ: PNTG) will likely slow down its acquisition activity during the remainder of the year and early 2022 as they work to recover from pandemic headwinds that bruised the hospice, home health and senior housing provider during the third quarter. Pennant has been aggressive on acquisitions during the past two years, including […]
The hospice mergers and acquisitions market has been burgeoning for the last several years and continues to accelerate. Hospice leads the health care sector in terms of investor interest and valuations, but providers may hit some walls if workforce shortages worsen. Among the driving forces behind this continued acceleration include demographic tailwinds, rising demand and […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
